{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-080355","form_type":"8-K","ticker":"GILD","cik":"0000882095","company_name":"GILEAD SCIENCES, INC.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.141662+00:00","generated_at":"2026-05-31T20:21:42.386448+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Gilead CMO Merdad Parsey to depart early 2025; successor search begins","bullets":["Chief Medical Officer Merdad Parsey, M.D., Ph.D., will leave Gilead early next year.","Parsey will remain CMO until Q1 2025 to assist with transition while successor is identified.","He joined Gilead in November 2019 and oversaw expansion of pipeline to 54 ongoing clinical trials.","CEO Daniel O'Day praised Parsey's role in doubling the portfolio and advancing virology, oncology, and inflammation.","No formal departure date; transition expected through Q1 2025 or as mutually agreed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-080355","json":"https://secwatch.observer/filing/0001104659-24-080355.json","markdown":"https://secwatch.observer/filing/0001104659-24-080355.md","text":"https://secwatch.observer/filing/0001104659-24-080355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/0001104659-24-080355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/tm2419649d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:21:42.386448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6bcb92bb5","claim":"Merdad V. Parsey resigned as Chief Medical Officer at GILEAD SCIENCES, INC..","evidence_excerpt":"announced that its Chief Medical Officer, Merdad V. Parsey, M.D., Ph.D., will leave the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/0001104659-24-080355-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}